Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men

NCT06923839 is registered in ClinicalTrials.gov with Oluf Pedersen as lead sponsor.

NCT NCT06923839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06923839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men
Lead sponsor
Oluf Pedersen
Phase
Phase 1
Overall status
Completed
Start date
July 28, 2025
Completion date
September 4, 2025
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy male adults